Related Experiment Video
Updated: Jan 4, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Exhaled volatile substances in children suffering from type 1 diabetes mellitus: results from a cross-sectional study
Phillip Trefz1, Juliane Obermeier2, Ruth Lehbrink3
1Department of Anesthesiology and Intensive Care Medicine, Rostock Medical Breath Research Analytics and Technologies (ROMBAT), Rostock University Medical Centre, Rostock, Germany. phillip.trefz@uni-rostock.de.
Insights
Analyzing exhaled volatile organic compounds (VOCs) offers a non-invasive method to monitor type 1 diabetes mellitus (T1DM) in children. T1DM patients show distinct VOC profiles, especially those with poor metabolic control.
Area of Science:
- Biochemistry
- Pediatrics
- Analytical Chemistry
Background:
- Monitoring metabolic adaptation in pediatric type 1 diabetes mellitus (T1DM) is complex.
- Exhaled breath volatile organic compounds (VOCs) present a promising, non-invasive diagnostic tool.
- Limited data exists on breath VOC profiles in children with T1DM.
Purpose of the Study:
- To quantitatively analyze exhaled VOCs in children with T1DM compared to healthy controls.
- To investigate the relationship between VOC profiles and disease characteristics like duration, insulin delivery method, and metabolic control.
- To assess the potential of breath analysis for early detection of metabolic changes in T1DM.
Main Methods:
- Cross-sectional study involving 53 children with T1DM and 60 age- and sex-matched healthy controls.
- Quantitative analysis of exhaled VOCs using proton-transfer-reaction time-of-flight mass spectrometry (PTR-TOF).
- Classification of T1DM patients based on disease duration, insulin delivery mode, and HbA1c levels.
Main Results:
- Significant differences in exhaled VOC concentrations were observed between T1DM patients and healthy children.
- T1DM patients exhibited higher levels of ethanol, isopropanol, dimethylsulfide, isoprene, and pentanal.
- The most pronounced VOC concentration differences were found in T1DM patients with poor metabolic control (HbA1c > 8%).
Conclusions:
- Non-invasive breath testing using VOC analysis is a viable tool for pediatric T1DM research.
- Breath VOC profiling can reveal metabolic adaptations and alterations in early-stage T1DM.
- This method may aid in understanding T1DM pathophysiology and monitoring disease progression.
Abstract:
Monitoring metabolic adaptation to type 1 diabetes mellitus in children is challenging. Analysis of volatile organic compounds (VOCs) in exhaled breath is non-invasive and appears as a promising tool. However, data on breath VOC profiles in pediatric patients are limited. We conducted a cross-sectional study and applied quantitative analysis of exhaled VOCs in children suffering from type 1 diabetes mellitus (T1DM) (n = 53) and healthy controls (n = 60). Both groups were matched for sex and age. For breath gas analysis, a very sensitive direct mass spectrometric technique (PTR-TOF) was applied. The duration of disease, the mode of insulin application (continuous subcutaneous insulin infusion vs. multiple daily insulin injection) and long-term metabolic control were considered as classifiers in patients. The concentration of exhaled VOCs differed between T1DM patients and healthy children. In particular, T1DM patients exhaled significantly higher amounts of ethanol, isopropanol, dimethylsulfid, isoprene and pentanal compared to healthy controls (171, 1223, 19.6, 112 and 13.5 ppbV vs. 82.4, 784, 11.3, 49.6, and 5.30 ppbV). The most remarkable differences in concentrations were found in patients with poor metabolic control, i.e. those with a mean HbA1c above 8%. In conclusion, non-invasive breath testing may support the discovery of basic metabolic mechanisms and adaptation early in the progress of T1DM.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin Secretory Vesicles
Asthma-III: Symptoms and Complications
Classification of Asthma
Diabetes Mellitus: Type 2 and Gestational
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

